MATTHEW FESHBACH

Since 2018, Matthew "Matt" Feshbach has served as founding CEO of Ambrose Cell Therapy, a Florida-based center focused on improving the lives of people living with complex chronic health conditions. The center accesses a patient's own adipose-derived stem and regenerative cells (ADRCs), ADRCs have shown potential for treating chronic diseases affecting various areas of the body. Matthew Feshbach's interest in ADRCs dates back to 2009, when he began researching stem cells as part of his investment activities. His research led to the 2011 founding of Okyanos Cell Therapy, a center he led until 2017.